Browse Category

Investing News 3 December 2025 - 4 December 2025

OCBC Stock (SGX: O39) Hits Record Highs: December 2025 Outlook, Analyst Targets, Dividends and Key Risks

OCBC Stock (SGX: O39) Hits Record Highs: December 2025 Outlook, Analyst Targets, Dividends and Key Risks

Oversea‑Chinese Banking Corporation Limited (OCBC, SGX: O39) is ending 2025 in rarefied air. Its shares have climbed to fresh record highs on the Singapore Exchange, powered by resilient third‑quarter earnings, a powerful wealth‑management franchise, and new digital‑payments initiatives such as
4 December 2025
Commonwealth Bank of Australia (ASX:CBA) Share Price in December 2025: Is the Market Re‑rating a Quality Giant or Pricing in Trouble for 2026?

Commonwealth Bank of Australia (ASX:CBA) Share Price in December 2025: Is the Market Re‑rating a Quality Giant or Pricing in Trouble for 2026?

Updated 4 December 2025 Commonwealth Bank of Australia (ASX:CBA) has gone from market darling to market headache in just a few months. As of early afternoon on 4 December 2025, CBA shares were trading around A$152–153, after closing at A$152.05
Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling – Is There Still Upside?

Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling – Is There Still Upside?

Newmont Corporation (NYSE: NEM), the world’s largest gold miner, has turned into one of 2025’s standout large-cap performers. As of the close on December 3, 2025, Newmont stock changed hands around $89–90 per share, giving the company a market capitalization
Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Key takeaways (as of December 3, 2025) Note: This article is for informational purposes only and is not investment advice. Always do your own research or consult a licensed professional before making investment decisions. Accenture stock today: Price action and
Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (NYSE: JNJ) is trading around $205–$206 per share on Wednesday, December 3, 2025, just shy of its 52‑week high of about $207.81, after a powerful rally that has lifted the stock roughly 40% this year. MarketBeat+2ChartMill+2 Today’s
1 85 86 87 88 89 213
Go toTop